BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33034130)

  • 21. RHD 1227 A and hybrid Rhesus box analysis in Thai RhD+ and RhD- blood donors: Prevalence, RHD zygosity, and molecular screening.
    Simtong P; Phothi R; Puapairoj C; Leelayuwat C; Romphruk AV
    Transfus Apher Sci; 2022 Dec; 61(6):103496. PubMed ID: 35810119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of weak D and DEL in Han population in Anhui Province, China.
    Chen Q; Li M; Li M; Lu XS; Lü R; Sun J; Liu Z
    Chin Med J (Engl); 2012 Sep; 125(18):3251-5. PubMed ID: 22964318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RHD genotype and zygosity analysis in the Chinese Southern Han D+, D- and D variant donors using the multiplex ligation-dependent probe amplification assay.
    Ji YL; Luo H; Wen JZ; Haer-Wigman L; Veldhuisen B; Wei L; Wang Z; Ligthart P; Lodén-van Straaten M; Fu YS; van der Schoot CE; Luo GP
    Vox Sang; 2017 Oct; 112(7):660-670. PubMed ID: 28833187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of RhD variant phenotypes among blood donors: A study from the coastal region of India.
    Polavarapu I; Mishra G; Shastry S; Kulkarni S
    Transfus Apher Sci; 2021 Aug; 60(4):103142. PubMed ID: 33962886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [System RH: screening of partials D with RHD/RHCE hybrid gene].
    Ouchari M; Jemni Yacoub S; Houissa B; Abdelkefi S; Chakroun T; Bouslama M; Jerray I; Belhedi S; Hmida S
    Transfus Clin Biol; 2013 Mar; 20(1):35-9. PubMed ID: 23523094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterisation of RhD variants in North Indian blood donor population.
    Khetan D; Verma A; Chaudhary RK; Shukla JS
    Transfus Med; 2020 Aug; 30(4):295-303. PubMed ID: 32488899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six years' experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations.
    Flegel WA; von Zabern I; Wagner FF
    Transfusion; 2009 Mar; 49(3):465-71. PubMed ID: 19243542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RHD genotyping of serological weak D phenotypes in the Iranian blood donors and patients.
    Oodi A; Daneshvar Z; Goudarzi S; Amirizadeh N
    Transfus Apher Sci; 2020 Oct; 59(5):102870. PubMed ID: 32660892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polymorphism of RHD gene among RhD negative and D variant blood donors from Qingdao region].
    Hu B; Feng Z; Zhu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Dec; 34(6):897-900. PubMed ID: 29188626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RHD allelic identification among D-Brazilian blood donors as a routine test using pools of DNA.
    Mota M; Dezan M; Valgueiro MC; Sakashita AM; Kutner JM; Castilho L
    J Clin Lab Anal; 2012 Feb; 26(2):104-8. PubMed ID: 22467325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RHD positive haplotypes in D negative Europeans.
    Wagner FF; Frohmajer A; Flegel WA
    BMC Genet; 2001; 2():10. PubMed ID: 11495631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The RHD(1227G>A) DEL-associated allele is the most prevalent DEL allele in Australian D- blood donors with C+ and/or E+ phenotypes.
    Scott SA; Nagl L; Tilley L; Liew YW; Condon J; Flower R; Hyland CA
    Transfusion; 2014 Nov; 54(11):2931-40. PubMed ID: 24894016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-D alloimmunisation in pregnant women with DEL phenotype in China.
    Wang M; Wang BL; Xu W; Fan DD; Peng ML; Pan J; Yao P; Jiang GM; Wan XJ
    Transfus Med; 2015 Jun; 25(3):163-9. PubMed ID: 26033335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive investigation of RHD polymorphisms in the Chinese Han population in Xi'an.
    Ye SH; Wu DZ; Wang MN; Wu XY; Xu HG; Xu H; Shao CP
    Blood Transfus; 2014 Jul; 12(3):396-404. PubMed ID: 24333088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary anti-D immunization by DEL red blood cells.
    Kim KH; Kim KE; Woo KS; Han JY; Kim JM; Park KU
    Korean J Lab Med; 2009 Aug; 29(4):361-5. PubMed ID: 19726900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RHD positive among C/E+ and D- blood donors in Denmark.
    Christiansen M; Sørensen BS; Grunnet N
    Transfusion; 2010 Jul; 50(7):1460-4. PubMed ID: 20456676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (C)ce(s) haplotype screening in Tunisian blood donors.
    Moussa H; Ghommen N; Romdhane H; Abdelkefi S; Chakroun T; Houissa B; Jemni SY
    Blood Transfus; 2014 Jul; 12(3):405-9. PubMed ID: 24333089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai.
    Li Q; Hou L; Guo ZH; Ye LY; Yue DQ; Zhu ZY
    Vox Sang; 2009 Aug; 97(2):139-46. PubMed ID: 19490579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of Multiplex Ligation-Dependent Probe Amplification Assay for Genotyping Major Blood Group Systems Including DEL Variants in the D-Negative Korean Population.
    Kim B; Lee ST; Kim S; Choi JR; Kim HO
    Ann Lab Med; 2018 Jan; 38(1):32-38. PubMed ID: 29071816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective molecular RHD typing strategy for blood donations.
    Polin H; Danzer M; Hofer K; Gassner W; Gabriel C
    Transfusion; 2007 Aug; 47(8):1350-5. PubMed ID: 17655577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.